Literature DB >> 884922

Kinetics of a sulfadiazine-trimethoprim combination.

T Bergan, H Vik-Mo, U Anstad.   

Abstract

The pharmacokinetics of a combination of sulfadiazine and trimethoprim has been studied in 16 patients with varying degrees of reduced renal function. In normal renal function, the serum half-life (t1/2) of active sulfadiazine, total sulfadiazine, and trimethoprim were quite close: 7.7, 9.6, and 12.1 hr, respectively. There was a gradual increase in serum t1/2 with reduction in renal function for both active and total sulfadiazine and for trimethoprim. With accurate determinations of endogenous renal clearance, t1/2 estimates may be made from regression curves presented. The relative distribution in the body was unrelated to renal function. It was similar for the two fractions of sulfonamide and higher for trimethoprim. The means were 0.371, 0.176, and 1.104 L/kg, respectively, for active and total sulfadiazine, and trimethoprim.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 884922     DOI: 10.1002/cpt1977222211

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  8 in total

1.  General survey of trimethoprim combinations in the treatment of urinary tract infections.

Authors:  W Brumfitt; J M Hamilton-Miller
Journal:  Infection       Date:  1979       Impact factor: 3.553

2.  Evaluation of acetylator phenotype, renal function and serum sulfadiazine levels in patients with paracoccidioidomycosis treated with cotrimazine (a combination of sulfadiazine and trimethoprim).

Authors:  B Barraviera; P C Pereira; R P Mendes; J M Machado; C R Lima; D A Meira
Journal:  Mycopathologia       Date:  1989-11       Impact factor: 2.574

3.  Pharmacokinetics of sulfadiazine and trimethoprim in man.

Authors:  F Andreasen; L Elsborg; S Husted; O Thomsen
Journal:  Eur J Clin Pharmacol       Date:  1978-11-09       Impact factor: 2.953

Review 4.  Clinical pharmacokinetics of co-trimazine.

Authors:  T Bergan; B Ortengren; D Westerlund
Journal:  Clin Pharmacokinet       Date:  1986 Sep-Oct       Impact factor: 6.447

5.  Clinical effect and pharmacokinetics of trimethoprim-sulphadiazine in children with urinary tract infections.

Authors:  J Aarbakke; O Opshaug; A Digranes; A Høylandskjaer; G Fluge; H Fellner
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

6.  Double-blind comparison of sulphonamide-trimethoprim combinations in acute uncomplicated urinary tract infections.

Authors:  O Skjerven; T Bergan
Journal:  Infection       Date:  1979       Impact factor: 3.553

Review 7.  The pharmacokinetics of trimethoprim and trimethoprim/sulphonamide combinations, including penetration into body tissues.

Authors:  D S Reeves; P J Wilkinson
Journal:  Infection       Date:  1979       Impact factor: 3.553

Review 8.  Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Authors:  G P Wormser; G T Keusch; R C Heel
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.